COMP <GO>
MMM vs MRK // ENTERPRISE SCALE & MARKET CAP
3M Company (NYSE) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: MMM 3
— MRK 11
▲ ENTERPRISE SCALE & MARKET CAP LEADER: MRK
LAST: $174.34 (-1.70%) • MKT CAP: $91.65B
market-cap
$91.65B
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
market-cap
$361.02B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MMM VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MMM | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 39.90% | 74.80% | -34.90 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 32.90% | 20.70% | +12.20 | MMM | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.1x | 15.3x | +2.80 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 1.52% | 3.42% | -1.90 | MRK | /fcf-yield <GO> |
| Operating Margin | 18.60% | 34.30% | -15.70 | MRK | /operating-margins <GO> |
| Net Profit Margin | 13.00% | 28.10% | -15.10 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 1.50% | 1.30% | +0.20 | MMM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.70% | 2.26% | -0.56 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.37 | 5.19 | -0.82 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 6.60% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.5 | 56.9 | +1.66 | MMM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.91 | 0.92 | -0.01 | MRK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.2x | 18.4x | +7.80 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $91.65B | $361.02B | -$269.37B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MMM REV | MRK REV | MMM GROSS % | MRK GROSS % | MMM FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $24.95B | $65.01B | 39.9% | 74.8% | $1.40B | $12.36B |
| FY 2024 | $24.57B | $64.17B | 41.2% | 76.3% | $638.0M | $18.10B |
| FY 2023 | $24.61B | $60.12B | 44.0% | 44.0% | $5.57B | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MMM // BETA 0.91
MRK // BETA 0.92